Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria

Abstract. Background: H1 antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case report: We report the case of a 28-year-old female patient suffering from chronic spontaneous urticaria who experienced severe episodes of wheals and flares induced by different H1 antihistamines. Methods: We performed skin prick tests (SPT) with a diversity of H1 antihistamines and CAST and FlowCAST analyses. Moreover, a placebo controlled oral challenge test to mizolastin was done. Results: We saw positive SPT reactions to nearly all H1 antihistamines tested with the exception of mizolastin. We observed neither a release of sulfidoleukotrienes nor an upregulation of basophil activation markers in the CAST and FlowCAST analyses. The oral challenge test with mizolastine resulted in the development of generalized wheals and flares. Conclusion: H1 antihistamines are effective drugs for the treatment of urticaria, but they may lead to hypersensitivity reactions in rare cases. Because of the negative CAST and FlowCAST results, an IgE-mediated pathomechanism is improbable. We propose that hypersensitivity reactions to H1 antihistamines may be induced by a paradox H1 receptor activation.

[1]  A. Tedeschi Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast. , 2009, European annals of allergy and clinical immunology.

[2]  Z. Ikezawa,et al.  Multiple H1‐antihistamine‐induced urticaria , 2009, The Journal of dermatology.

[3]  P. Rodríguez Del Río,et al.  Urticaria caused by antihistamines: report of 5 cases. , 2009, Journal of investigational allergology & clinical immunology.

[4]  T. Zuberbier,et al.  Allergological approach to drug hypersensitivity reactions , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[5]  F. Simons Advances in H1-antihistamines. , 2004, The New England journal of medicine.

[6]  J. Ring,et al.  Anaphylaxis to mizolastine. , 2004, The Journal of allergy and clinical immunology.

[7]  Mu-Hyoung Lee,et al.  Cutaneous drug eruption from cetirizine and hydroxyzine. , 2004, Journal of the American Academy of Dermatology.

[8]  P. Demoly,et al.  Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations , 2003, Allergy.

[9]  P. Demoly,et al.  General considerations for skin test procedures in the diagnosis of drug hypersensitivity , 2002, Allergy.

[10]  I. Hall,et al.  Pharmacogenetics of asthma. , 2000, The European respiratory journal.

[11]  P. Barranco,et al.  Anaphylactic reaction due to diphenhydramine , 1998, Allergy.